Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1360

1.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
3.

Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

Ereshefsky L, Riesenman C, Lam YW.

Clin Pharmacokinet. 1995;29 Suppl 1:10-8; discussion 18-9. Review.

PMID:
8846618
4.

Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors.

Naranjo CA, Sproule BA, Knoke DM.

Int Clin Psychopharmacol. 1999 May;14 Suppl 2:S35-47. Review.

PMID:
10471171
5.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Baumann P.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. Review.

PMID:
8968657
6.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
7.

Metabolic drug interactions with new psychotropic agents.

Spina E, Scordo MG, D'Arrigo C.

Fundam Clin Pharmacol. 2003 Oct;17(5):517-38. Review.

PMID:
14703714
8.
9.

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.

Hemeryck A, Belpaire FM.

Curr Drug Metab. 2002 Feb;3(1):13-37. Review.

PMID:
11876575
10.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
11.

Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.

Baumann P, Rochat B.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 1:15-21. Review.

PMID:
7622807
12.

Overview of the pharmacokinetics of fluvoxamine.

van Harten J.

Clin Pharmacokinet. 1995;29 Suppl 1:1-9. Review.

PMID:
8846617
13.

Clinically significant drug interactions with antidepressants in the elderly.

Spina E, Scordo MG.

Drugs Aging. 2002;19(4):299-320. Review.

PMID:
12038880
14.

Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors.

Lane RM.

Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:31-61. Review. Erratum in: Int Clin Psychopharmacol 1997 Mar;12(2):126.

PMID:
9032002
15.

Pharmacokinetics of selective serotonin reuptake inhibitors.

Hiemke C, Härtter S.

Pharmacol Ther. 2000 Jan;85(1):11-28. Review.

PMID:
10674711
16.

Differences in interactions of SSRIs.

Brøsen K.

Int Clin Psychopharmacol. 1998 Sep;13 Suppl 5:S45-7. Review.

PMID:
9817620
17.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
18.

Are pharmacokinetic drug interactions with the SSRIs an issue?

Brøsen K.

Int Clin Psychopharmacol. 1996 Mar;11 Suppl 1:23-7. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8732441
19.

Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Edwards JG, Anderson I.

Drugs. 1999 Apr;57(4):507-33. Erratum in: Drugs 1999 Dec;58(6):1207-9.

PMID:
10235690
20.

The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.

Daniel WA, Syrek M, Haduch A, Wójcikowski J.

J Pharm Pharmacol. 2001 Apr;53(4):449-61.

PMID:
11341361

Supplemental Content

Support Center